Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000300591

Medchemexpress LLC (-)-carvone | 6485-40-1 | MFCD00001578 | 99.9% | 150.22 g/mol | C10H14O | 100 G
SDP

Catalog No. 5000300591
Encompass_Preferred

(-)-Carvone (CAS 6485-40-1) is the levorotatory enantiomer of carvone, supplied as a high-purity research chemical for analytical and laboratory use. It serves as a reference standard and reagent in neurotoxicology studies, chemical synthesis, and method development, and is accompanied by product documentation including an SDS and datasheet.

  • High purity (99.91%) for analytical and research use.
  • Suitable as a reference standard and reagent.
  • Common applications include neurotoxicology, synthesis, and analytical method development.
  • Available in laboratory package sizes with SDS and product datasheet.

Catalog No. 50-003-00591 Supplier Medchemexpress LLC Supplier No. HYW017423100G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

(-)-Carvone (CAS 6485-40-1) is the levorotatory enantiomer of carvone, supplied as a high-purity research chemical for analytical and laboratory use. It serves as a reference standard and reagent in neurotoxicology studies, chemical synthesis, and method development, and is accompanied by product documentation including an SDS and datasheet.

  • High purity (99.91%) for analytical and research use.
  • Suitable as a reference standard and reagent.
  • Common applications include neurotoxicology, synthesis, and analytical method development.
  • Available in laboratory package sizes with SDS and product datasheet.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.